• Giuseppe Santarpino, Theodor Fischlein, Giovanni Concistrè, and Steffen Pfeiffer.
• Department of Cardiac Surgery, Klinikum Nürnberg, Nuremberg, Germany.
• Interact Cardiovasc Thorac Surg. 2012 Oct 1; 15 (4): 764-5.

AbstractRecently, small case series have described the successful off-label use of transcatheter valve implantation in patients with degenerated bioprosthetic valves in the mitral position. We report here the case of a 78-year old female patient who underwent transcatheter aortic valve implantation for severe aortic stenosis and transapical valve-in-valve implantation for a degenerated mitral bioprosthesis. There was no evidence of intraprosthetic regurgitation and/or paraprosthetic leakages on control angiography and transoesophageal echocardiography. The postoperative course was uneventful. Following accurate patient selection and evaluation by an experienced multidisciplinary team, the transcatheter approach to double-valve implantation in the aortic and mitral positions may represent a viable treatment option for those high-risk patients who would otherwise be inoperable. We preferred a two-step approach, considering a single procedure to be high-risk.

24 keywords...

hide…